白血病临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 白血病（国际通用名 leukemia）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖急性髓系白血病、AML、急性淋巴细胞白血病、ALL、慢性淋巴细胞白血病等说法。

正在招募的白血病新药试验

• Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)

  II 期招募中美国NCT05536349

• Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III Trial

  不适用招募中意大利NCT07420790

• Current Practice of Ventilation Strategies in Children Undergoing General Anesthesia

  不适用招募中澳大利亚意大利NetherlandsSwitzerlandNCT06166706

• Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  II 期招募中西班牙NCT06544785

• A Retrospective Study on the Relationship Between Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation

  不适用招募中中国NCT06076226

• Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment

  I 期招募中NorwayNCT07651878

• Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients

  不适用招募中法国NCT07250217

• Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCN

  I 期招募中中国NCT06690827

• The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients

  不适用招募中美国NCT05876923

• Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia

  III 期招募中中国NCT06802718

• Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

  IV 期招募中美国NCT07486713

• Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

  II 期招募中美国Puerto RicoNCT06672146